{"summary":"Ashish Mandelia is the current Vice President, Controller of Mersana Therapeutics, Inc., headquartered in Cambridge, Massachusetts. Mersana is a clinical stage biopharmaceutical company focused on developing antibody drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with significant unmet need.\n\nBefore joining Mersana, he was the Senior Director, Technical Accounting at Tesaro, Inc., headquartered in Waltham, Massachusetts. GlaxoSmithKline plc (GSK) acquired Tesaro for an aggregate consideration of $5.1 billion in January 2019. Tesaro was a commercial-stage biopharmaceutical company devoted to providing transformative therapies to people bravely facing cancer. \n\nPrior to that, he worked at PricewaterhouseCoopers (PwC) in Boston and London, providing audit services to various public and privately held pharmaceutical and biotech companies for more than 11 years. He graduated from the University of Mumbai and has obtained his Master\u2019s in Business Administration from Suffolk University in Boston. He is a Certified Public Accountant.","lastName":"Mandelia","objectUrn":"urn:li:member:32312979","geoRegion":"Boston, Massachusetts, United States","fullName":"Ashish Mandelia","firstName":"Ashish","currentPositions":[{"companyName":"Mersana Therapeutics","title":"Vice President, Chief Accounting Officer","tenureAtCompany":{"numYears":4,"numMonths":11},"companyUrnResolutionResult":{"employeeCountRange":"51-200","headquarters":{"geographicArea":"MA","country":"United States","city":"Cambridge","postalCode":"02139","line1":"840 Memorial Drive"},"website":"http:\/\/www.mersana.com","flagshipCompanyUrl":"https:\/\/www.linkedin.com\/company\/mersana-therapeutics\/","industry":"Biotechnology Research"},"startedOn":{"month":9,"year":2023},"companyUrn":"urn:li:fs_salesCompany:145888"}],"entityUrn":"urn:li:fs_salesProfile:(ACwAAAHtDpMBmWtCVSXHah-X35PsNTFkc_i0URs,NAME_SEARCH,cOY9)","profilePictureDisplayImage":{"artifacts":[{"width":100,"fileIdentifyingUrlPathSegment":"100_100\/0\/1623114878074?e=1723075200&v=beta&t=aGL-lH1gbRy4Q7wR0ZAzYHayOyEcWE-NGGh4kd7aV2E","height":100},{"width":200,"fileIdentifyingUrlPathSegment":"200_200\/0\/1623114878074?e=1723075200&v=beta&t=n4f8ROz-DSG7aMhX9LXf3FaKSlCsiwXU5fdthx4J8tg","height":200},{"width":400,"fileIdentifyingUrlPathSegment":"400_400\/0\/1623114878074?e=1723075200&v=beta&t=3X7GygwtosBRlHapRQRuhFUjiHkWykjLSTrVaup5fnQ","height":400},{"width":800,"fileIdentifyingUrlPathSegment":"800_800\/0\/1623114878074?e=1723075200&v=beta&t=_gD8xshuguATTHn-Pmi6Tt66Z3qjQwLKLqOrnuAr6b0","height":800}],"rootUrl":"https:\/\/media.licdn.com\/dms\/image\/C4D03AQFIOUlOp8LQJg\/profile-displayphoto-shrink_"},"projects":[],"contactInfo":{"socialHandles":[{"type":"TWITTER","name":"aarishman","dataSource":"LINKEDIN"}]},"industry":"Biotechnology Research","educations":[{"endedOn":{"month":4,"year":2023},"degree":"General Management Program","eduId":854887004,"schoolUrn":"urn:li:fs_salesSchool:4867","school":"urn:li:fs_salesSchool:4867","fieldsOfStudy":["Executive MBA"],"schoolName":"Harvard Business School","startedOn":{"month":1,"year":2023}},{"endedOn":{"year":2008},"degree":"2008\t\tCPA","eduId":37321773,"fieldsOfStudy":["Accounting"],"schoolName":"Massachusetts State Board of Accountancy","startedOn":{"year":2007}},{"endedOn":{"year":2002},"degree":"2002\t\tMBA","eduId":37321780,"schoolUrn":"urn:li:fs_salesSchool:15101196","school":"urn:li:fs_salesSchool:15101196","fieldsOfStudy":["Finance"],"schoolName":"Suffolk University - Sawyer Business School","startedOn":{"year":2000}},{"endedOn":{"year":1994},"degree":"Bachelor of Commerce - BCom","schoolUrn":"urn:li:fs_salesSchool:15093732","eduId":602622649,"school":"urn:li:fs_salesSchool:15093732","schoolName":"University of Mumbai"}],"skills":[{"numOfEndorsement":1,"name":"SEC filings"},{"numOfEndorsement":7,"name":"Sarbanes-Oxley Act"},{"numOfEndorsement":1,"name":"Corporate Governance"},{"numOfEndorsement":1,"name":"Risk Assessment"},{"numOfEndorsement":1,"name":"Portfolio Management"},{"numOfEndorsement":2,"name":"Business Development"},{"numOfEndorsement":1,"name":"US GAAP"},{"numOfEndorsement":8,"name":"Internal Controls"},{"numOfEndorsement":8,"name":"Auditing"},{"numOfEndorsement":1,"name":"Revenue Recognition"},{"numOfEndorsement":1,"name":"Financial Reporting"},{"numOfEndorsement":4,"name":"Accounting"},{"numOfEndorsement":1,"name":"GAAP"},{"numOfEndorsement":2,"name":"Financial Analysis"},{"numOfEndorsement":1,"name":"Internal Audit"},{"numOfEndorsement":2,"name":"IFRS"},{"numOfEndorsement":1,"name":"CPA"},{"numOfEndorsement":1,"name":"Assurance"},{"numOfEndorsement":1,"name":"Financial Accounting"},{"numOfEndorsement":1,"name":"IPO"},{"numOfEndorsement":1,"name":"Forecasting"},{"numOfEndorsement":3,"name":"Sarbanes-Oxley"}],"pronoun":"He\/Him","numOfConnections":880,"patents":[],"headline":"Vice President, Chief Accounting Officer at Mersana Therapeutics","courses":[],"certifications":[],"memberBadges":{"premium":false,"openLink":false,"jobSeeker":false},"flagshipProfileUrl":"https:\/\/www.linkedin.com\/in\/mandelia","organizations":[],"location":"Boston, Massachusetts, United States","publications":[],"positions":null,"posts":[{"createdAt":1709918100000,"insightId":"abbb25f7-e372-449d-a05d-28956ad600c8","activityUnion":{"postActivity":{"contentSummaryUnion":{"referenceContentSummary":{"entityUrn":"urn:li:job:3728036132"}},"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":28},{"type":"PRAISE","count":1},{"type":"APPRECIATION","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7171916490512805889","threadUrn":"urn:li:activity:7171916490512805889","reactionsCount":30,"commentsCount":0,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7171916490072395776","message":{"attributes":[{"start":143,"length":19,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:patientsarewaiting"}}}],"text":"Check out this job at Mersana Therapeutics: Director\/Senior Director, Outsourcing and Vendor Management \n\nGreat opportunity to make an impact! #patientsarewaiting"},"entityUrn":"urn:li:share:7171916490072395776"}}},{"createdAt":1717155240000,"insightId":"3d00b92c-2098-44ba-8fcd-2651e679a78b","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7202173479729692672,7202271196158078977)","threadUrn":"urn:li:activity:7202173479729692672","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Congratulations, Anupam!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7202173479729692672"}}},{"createdAt":1711382820000,"insightId":"cc61981d-17b3-4fec-bcf6-e0e6eb6b294d","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7178048118733553665,7178060006238384129)","threadUrn":"urn:li:activity:7178048118733553665","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Congratulations Amol!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7178048118733553665"}}}]}